title: Neuroleptic malignant syndrome following BMT.
authors.forename: M
authors.initials: M
authors.lastname: Onose
authors.forename: C
authors.initials: C
authors.lastname: Kawanishi
authors.forename: H
authors.initials: H
authors.lastname: Onishi
authors.forename: T
authors.initials: T
authors.lastname: Yamada
authors.forename: M
authors.initials: M
authors.lastname: Itoh
authors.forename: K
authors.initials: K
authors.lastname: Kosaka
authors.forename: J
authors.initials: J
authors.lastname: Taguchi
authors.forename: S
authors.initials: S
authors.lastname: Fujisawa
authors.forename: H
authors.initials: H
authors.lastname: Kanamori
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications / Q000628:therapy; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*
chemical_list: D006220:Haloperidol